Guangdong Eashu Pharmaceutical

Guangdong Eashu Pharmaceutical is a Chinese pharmaceutical manufacturer based in Zhaoqing, Guangdong, focused on the development, production, and sale of finished drugs and active pharmaceutical ingredients. Publicly available information indicates the company manufactures mainly small-molecule products, including gastrointestinal medicines, anti-infectives, antihistamines, cardiovascular-related products, and APIs. The company has conducted bioequivalence studies for omeprazole and esomeprazole products, indicating a largely generics-oriented pipeline rather than a novel-drug discovery strategy. It was founded in 2000 and previously traded on China’s National Equities Exchange and Quotations system under ticker 832796 before terminating its NEEQ quotation in 2025. The business appears to remain operational as an active pharmaceutical manufacturing company with commercialized products and manufacturing capabilities in oral solid dosage forms and APIs.